US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 91.440
  • +0.590+0.65%
Close Aug 8 16:00 ET
  • 90.400
  • -1.040-1.14%
Pre 08:00 ET
5.79BMarket Cap-26815P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 1, 2024

Revenue(YoY)

138.16M

+139.98%
EPS(YoY)

-0.80

+63.47%
Analyst Rating

Strong Buy

Aug 8, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 134.403M--
--2024/Q3-- / 125.742M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 134.403M--
--2024/Q3-- / 125.742M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:52 ET

  • Blueprint Medicines | 10-Q: Q1 2024 Earnings Report

    May 2 16:51 ET

  • Blueprint Medicines | 10-K: FY2023 Annual Report

    Feb 15 22:20 ET

  • Blueprint Medicines | 10-Q: Q3 2023 Earnings Report

    Oct 26, 2023 16:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 8, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Cancer Research
    Cancer Research
    Intraday+0.71%